Press releases

Month Year

Email alerts

Jun 8, 2019

Medtronic Initiates Pivotal Trial for Next-Generation Guardian(TM) Continuous Glucose Monitoring Sensor

DUBLIN - June 8, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has initiated the company's pivotal trial for its next-generation Guardian(TM)...
Jun 7, 2019

Medtronic and Tidepool Work Together on Interoperable Automated Insulin Pump System for Diabetes Management

DUBLIN and PALO ALTO, Calif. - June 7, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, and Tidepool, a 501(c)(3) nonprofit organization dedicated...
May 28, 2019

MiniMed(TM) 670G System Real-World Data on 8 Million Patient Days Shows 71 Percent Time in Range Across All Age Groups

DUBLIN - May 28, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world clinical outcomes for the MiniMed(TM) 670G system, which is being used by more...
May 9, 2019

New Study Demonstrates Safety and Effectiveness of the MiniMed(TM) 640G System Reducing Hypoglycemia Compared with Insulin Pump Therapy Without CGM in Type 1 Diabetes

DUBLIN – May 9, 2019 – Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the publication of the SMILE study in The Lancet Diabetes & Endocrinology.1The SMILE...
Apr 8, 2019

New Value-Based Agreement Between Blue Cross and Blue Shield of Minnesota and Medtronic Leverages Diabetes Technology to Drive Positive Outcomes

Agreement Focuses on the Guardian Connect Smart CGM System, Improved Member Engagement and Measuring Time in Range

MINNEAPOLIS and DUBLIN - April 8, 2019 - Blue Cross and Blue Shield of Minnesota and Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, announce a new...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa